Edition:
United Kingdom

People: Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,986.00GBp
4:41pm BST
Change (% chg)

50.00 (+1.70%)
Prev Close
2,936.00
Open
2,964.00
Day's High
3,000.00
Day's Low
2,936.00
Volume
150,357
Avg. Vol
169,524
52-wk High
3,163.00
52-wk Low
1,992.00

Eldred, Mike 

Mr. Mike Eldred, BA, MBA is a President, North America of Dechra Pharmaceuticals PLC. Mike joined Dechra in 2004 and is responsible for Dechra Veterinary Products’ North American business. Mike has more than 20 years’ experience in the animal health sector, having held senior positions in business development, sales and operations at Virbac Corporation, Fort Dodge Animal Health and Sanofi Animal Health. As our first employee in the US, he has built the US and Canadian team to 169 people and with a strong Dechra culture has grown sales revenue to £148.4 million. Mike has also been involved in several commercial agreements and acquisitions for the Group including Pharmaderm, DermaPet, Phycox Animal Health and Putney. Mike has a BA in Business, and an MBA. He is located in Kansas, USA.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Rice

126,000

Ian Page

3,536,000

Paul Sandland

--

Mike Eldred

--

Anthony Griffin

1,195,000

Katy Clough

--
As Of  30 Jun 2018